Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study.
Saved in:
| Title: | Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study. |
|---|---|
| Authors: | Broen MPG; Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Beckers R; Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands., Willemsen ACH; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.; Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, the Netherlands.; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Huijs SMH; Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands., Pasmans RCOS; Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands., Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Ackermans L; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands., Beckervordersandforth J; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.; Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands., van Raak EPM; Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands., Verduin M; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Anten MHME; Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Hoeben A; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., Postma AA; Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2022 Mar 30; Vol. 4 (1), pp. vdac038. Date of Electronic Publication: 2022 Mar 30 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
